Complaint & PMS Governance Services

Medical device complaints commonly include product malfunctions, labeling issues, packaging defects, use errors, adverse events, performance failures, and quality concerns reported by customers or users. They may be reportable or non-reportable depending on the event details and regulatory criteria. A strong complaint system classifies each complaint accurately, documents the investigation, and links findings to CAPA, risk management, and post-market surveillance activities.

The five core steps are intake, evaluation, investigation, reportability assessment, and closure. Intake captures complete event details. Evaluation confirms classification and severity. Investigation determines cause and supporting evidence. Reportability assessment checks whether FDA MDR, EU vigilance, or other submissions are required. Closure documents conclusions, actions taken, and any links to CAPA, PMS trending, or risk file updates.

Complaint handling is critical because it directly affects patient safety, regulatory compliance, and market continuity. Regulators expect manufacturers to review complaints promptly, investigate appropriately, assess reportability, and identify trends that may indicate broader safety issues. Weak complaint handling can lead to missed reporting deadlines, audit findings, CAPA failures, and enforcement actions that disrupt commercial operations.

Complaint governance is a core input to post-market surveillance because complaint records often reveal recurring failures, adverse trends, and emerging safety signals. Those findings should feed PMS reports, PSURs, PMSRs, CAPA decisions, and risk management updates. When complaint handling and PMS are integrated, manufacturers can move beyond isolated case review and maintain a more proactive, evidence-based post-market system.

A complaint becomes reportable when the event meets the criteria defined by the applicable authority, such as FDA MDR requirements under 21 CFR Part 803 or EU MDR vigilance obligations. This usually involves death, serious injury, or a malfunction that could lead to serious harm if it recurred. A documented reportability assessment should evaluate event facts, device involvement, severity, and regulatory timelines.

A complaint investigation should include the event description, device identification, lot or serial details, initial classification, evaluation of returned product if available, root cause analysis where appropriate, reportability determination, and documented conclusions. It should also show whether corrective actions, CAPA, labeling review, supplier review, or risk file updates were considered. The record must be complete enough to withstand audit and inspection scrutiny.

Trend review frequency should match the device risk profile, complaint volume, and regulatory commitments, but many manufacturers review monthly or quarterly. Higher-risk devices or rapidly growing portfolios may require more frequent analysis. Reviews should look for recurring failure modes, lot-specific issues, geographic patterns, and severity shifts. The output should be documented and tied to management review, CAPA, and post-market reporting obligations.

Yes, outsourced governance can meet regulatory expectations when responsibilities, review criteria, timelines, and documentation standards are clearly defined. The manufacturer still retains ultimate responsibility, but an experienced external partner can strengthen consistency, improve investigation quality, support reportability decisions, and maintain surveillance discipline. The key is having auditable workflows, clear oversight, and integration with the manufacturer’s quality system and regulatory obligations.